HealthCare Global Enterprises (NSE:HCG) ROCE %: 6.05% (As of Mar. 2026)


NSE:HCG HealthCare Global Enterprises Ltd NSE:HCG
79 GF Score
Price ₹600.40
GF Value ₹576.14
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is HealthCare Global Enterprises ROCE %?

HealthCare Global Enterprises NSE:HCG -2.25% 79 ROCE % is 6.05% as of Mar. 2026. GuruFocus rates NSE:HCG with a GF Score™ of 79/100 and a GF Value™ of ₹576.14 (Fairly Valued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. HealthCare Global Enterprises's annualized ROCE % for the quarter that ended in Mar. 2026 was 6.05%.

HealthCare Global Enterprises  (NSE:HCG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

HealthCare Global Enterprises ROCE % Related Terms

HealthCare Global Enterprises ROCE % Historical Data

* Premium members only.

The historical data trend for HealthCare Global Enterprises's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthCare Global Enterprises ROCE % Chart

HealthCare Global Enterprises Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.51 7.97 9.08 9.48 7.53

HealthCare Global Enterprises Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.26 9.19 9.97 6.08 6.05
NSE:HCG
79GF Score
HealthCare Global Enterprises Ltd NSE:HCG
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthCare Global Enterprises ROCE % Calculation

HealthCare Global Enterprises's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=2034.9/( ( (35432.36 - 10464.18) + (39225.4 - 10171.6) )/ 2 )
=2034.9/( (24968.18+29053.8)/ 2 )
=2034.9/27010.99
=7.53 %

HealthCare Global Enterprises's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=1758/( ( (0 - 0) + (39225.4 - 10171.6) )/ 1 )
=1758/( ( 0 + 29053.8 )/ 1 )
=1758/29053.8
=6.05 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.05% mean?
HealthCare Global Enterprises (NSE:HCG) has a ROCE % of 6.05% as of Mar. 2026.
Is HealthCare Global Enterprises' ROCE % too high?
HealthCare Global Enterprises' current ROCE % is 6.05%. The Healthcare Providers & Services industry median ROCE % is 6.41. HealthCare Global Enterprises' value of 6.05% is 5.6% below this industry median. Overall, HealthCare Global Enterprises has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' ROCE % compare to HCA and THC?
HealthCare Global Enterprises' ROCE % of 6.05% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. HealthCare Global Enterprises' value of 6.05% is 5.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthCare Global Enterprises's current ROCE % of 6.05% is 5.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthCare Global Enterprises's current ROCE % is 6.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Fairly Valued. The stock's GF Value™ is ₹576.14, compared to a current price of ₹600.40 — trading 4.2% above its estimated fair value. The current ROCE % is 6.05% and 5.6% below the Healthcare Providers & Services industry median of 6.41. HealthCare Global Enterprises' overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current ROCE % is 6.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?

Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued. The current stock price of ₹600.40 is trading 4.2% above its estimated GF Value™ of ₹576.14. GuruFocus considers HealthCare Global Enterprises to be Fairly Valued.

Key valuation signals for NSE:HCG:

  • ROCE %: 6.05%
  • GF Value™: ₹576.14 vs. price of ₹600.40 (4.2% above fair value)
  • GF Score™: 79/100 with 2 warning signs
  • Industry Position: 5.6% below the Healthcare Providers & Services median

No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HealthCare Global Enterprises Business Description

Other Exchanges 539787:India
Address Mission Road, No. 3, Ground Floor, Tower Block, Unity Building Complex, Bengaluru, KA, IND, 560027
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
79GF Score

Get the complete analysis for NSE:HCG

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹600.40
Price
₹576.14
GF Value